Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Cody R. Eslinger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8057-0841; OpenAlex author ID A5046692471. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 4

  1. Harnessing novel agents to target KRAS-driven pathways in pancreatic cancer. Co-author DOI 10.1080/14712598.2026.2738708↗
  2. Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm. Co-author DOI 10.2147/dddt.s559325↗
  3. Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Co-author DOI 10.1136/gutjnl-2016-313133↗
  4. Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2016.07.023↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tanios Bekaii‐Saab · 2 shared papers, 2026 · strength 0.79
  2. Joanna Kreidi · 1 shared paper, 2026 · strength 0.43
  3. Mitesh J. Borad · 1 shared paper, 2026 · strength 0.36
  4. Mohamad Bassam Sonbol · 1 shared paper, 2026 · strength 0.36
  5. Ben George · 1 shared paper, 2026 · strength 0.36
  6. Hani M. Babiker · 1 shared paper, 2026 · strength 0.36
  7. Erik S. Knudsen · 2 shared papers, 2016–2018 · strength 0.15
  8. Agnieszka Katarzyna Witkiewicz · 2 shared papers, 2016–2018 · strength 0.15
  9. Gordon Brent Mills · 1 shared paper, 2016 · strength 0.06
  10. William Charles Conway · 1 shared paper, 2016 · strength 0.06
  11. Eileen Mary O'Reilly · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.